Citigroup’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.9K | Sell |
48,544
-48,424
| -50% | -$45.8K | ﹤0.01% | 4076 |
|
2025
Q1 | $44.7K | Sell |
96,968
-9,818
| -9% | -$4.52K | ﹤0.01% | 4136 |
|
2024
Q4 | $78.9K | Buy |
106,786
+17,041
| +19% | +$12.6K | ﹤0.01% | 4094 |
|
2024
Q3 | $141K | Buy |
89,745
+56,615
| +171% | +$88.9K | ﹤0.01% | 3820 |
|
2024
Q2 | $55.7K | Buy |
33,130
+15,582
| +89% | +$26.2K | ﹤0.01% | 3788 |
|
2024
Q1 | $42.1K | Sell |
17,548
-207,450
| -92% | -$498K | ﹤0.01% | 3964 |
|
2023
Q4 | $344K | Buy |
224,998
+188,983
| +525% | +$289K | ﹤0.01% | 2918 |
|
2023
Q3 | $39.3K | Buy |
36,015
+2,528
| +8% | +$2.76K | ﹤0.01% | 3524 |
|
2023
Q2 | $76.7K | Buy |
33,487
+29,442
| +728% | +$67.4K | ﹤0.01% | 3698 |
|
2023
Q1 | $9.83K | Sell |
4,045
-172
| -4% | -$418 | ﹤0.01% | 4078 |
|
2022
Q4 | $8.05K | Sell |
4,217
-420
| -9% | -$802 | ﹤0.01% | 4199 |
|
2022
Q3 | $11K | Sell |
4,637
-11,916
| -72% | -$28.3K | ﹤0.01% | 4219 |
|
2022
Q2 | $31K | Buy |
16,553
+7,877
| +91% | +$14.8K | ﹤0.01% | 4090 |
|
2022
Q1 | $18K | Sell |
8,676
-14,931
| -63% | -$31K | ﹤0.01% | 4465 |
|
2021
Q4 | $93K | Buy |
23,607
+14,672
| +164% | +$57.8K | ﹤0.01% | 4007 |
|
2021
Q3 | $43K | Sell |
8,935
-2,660
| -23% | -$12.8K | ﹤0.01% | 4070 |
|
2021
Q2 | $53K | Buy |
11,595
+8,124
| +234% | +$37.1K | ﹤0.01% | 4123 |
|
2021
Q1 | $20K | Sell |
3,471
-88,416
| -96% | -$509K | ﹤0.01% | 4591 |
|
2020
Q4 | $314K | Sell |
91,887
-12,296
| -12% | -$42K | ﹤0.01% | 2948 |
|
2020
Q3 | $150K | Buy |
104,183
+91,950
| +752% | +$132K | ﹤0.01% | 2925 |
|
2020
Q2 | $24K | Sell |
12,233
-6,370
| -34% | -$12.5K | ﹤0.01% | 4138 |
|
2020
Q1 | $36K | Buy |
18,603
+715
| +4% | +$1.38K | ﹤0.01% | 4031 |
|
2019
Q4 | $74K | Sell |
17,888
-30,505
| -63% | -$126K | ﹤0.01% | 3718 |
|
2019
Q3 | $146K | Sell |
48,393
-93,931
| -66% | -$283K | ﹤0.01% | 3256 |
|
2019
Q2 | $895K | Buy |
142,324
+29,885
| +27% | +$188K | ﹤0.01% | 2224 |
|
2019
Q1 | $626K | Sell |
112,439
-285,205
| -72% | -$1.59M | ﹤0.01% | 2326 |
|
2018
Q4 | $2.64M | Buy |
397,644
+129,687
| +48% | +$861K | ﹤0.01% | 1360 |
|
2018
Q3 | $2.86M | Buy |
267,957
+99,771
| +59% | +$1.06M | ﹤0.01% | 1293 |
|
2018
Q2 | $2.02M | Buy |
168,186
+108,333
| +181% | +$1.3M | ﹤0.01% | 1472 |
|
2018
Q1 | $513K | Sell |
59,853
-18,105
| -23% | -$155K | ﹤0.01% | 2290 |
|
2017
Q4 | $770K | Buy |
77,958
+4,866
| +7% | +$48.1K | ﹤0.01% | 2052 |
|
2017
Q3 | $899K | Buy |
73,092
+29,162
| +66% | +$359K | ﹤0.01% | 2011 |
|
2017
Q2 | $723K | Buy |
43,930
+1,819
| +4% | +$29.9K | ﹤0.01% | 2191 |
|
2017
Q1 | $604K | Sell |
42,111
-108,989
| -72% | -$1.56M | ﹤0.01% | 2290 |
|
2016
Q4 | $2.09M | Buy |
151,100
+124,391
| +466% | +$1.72M | ﹤0.01% | 1810 |
|
2016
Q3 | $483K | Buy |
26,709
+13,044
| +95% | +$236K | ﹤0.01% | 2451 |
|
2016
Q2 | $196K | Sell |
13,665
-28,861
| -68% | -$414K | ﹤0.01% | 2883 |
|
2016
Q1 | $508K | Buy |
42,526
+36,492
| +605% | +$436K | ﹤0.01% | 2669 |
|
2015
Q4 | $80K | Sell |
6,034
-45,219
| -88% | -$600K | ﹤0.01% | 3738 |
|
2015
Q3 | $550K | Buy |
51,253
+36,460
| +246% | +$391K | ﹤0.01% | 2146 |
|
2015
Q2 | $119K | Sell |
14,793
-1,304
| -8% | -$10.5K | ﹤0.01% | 3131 |
|
2015
Q1 | $106K | Sell |
16,097
-5,787
| -26% | -$38.1K | ﹤0.01% | 3367 |
|
2014
Q4 | $139K | Buy |
21,884
+17,876
| +446% | +$114K | ﹤0.01% | 3418 |
|
2014
Q3 | $40K | Sell |
4,008
-283
| -7% | -$2.82K | ﹤0.01% | 3819 |
|
2014
Q2 | $48K | Sell |
4,291
-12,056
| -74% | -$135K | ﹤0.01% | 3583 |
|
2014
Q1 | $198K | Buy |
16,347
+361
| +2% | +$4.37K | ﹤0.01% | 2873 |
|
2013
Q4 | $202K | Buy |
15,986
+1,331
| +9% | +$16.8K | ﹤0.01% | 3139 |
|
2013
Q3 | $244K | Buy |
14,655
+12,050
| +463% | +$201K | ﹤0.01% | 2449 |
|
2013
Q2 | $40K | Buy |
+2,605
| New | +$40K | ﹤0.01% | 3884 |
|